Scientific principles and clinical implications of perioperative glucose regulation and control

Anesthesia and Analgesia

Volumn 110, Issue 2, 2010, Pages 478-497

  Akhtar, Shamsuddin ^a   Barash, Paul G ^a   Inzucchi, Silvio E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BILIRUBIN; CARBOHYDRATE; CATECHOLAMINE; CLONIDINE; DESFLURANE; DEXMEDETOMIDINE; DOPAMINE; GLUCOSE; HEMOGLOBIN A1C; ICODEXTRIN; INFUSION FLUID; INHALATION ANESTHETIC AGENT; INSULIN; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; LEVODOPA; MANNITOL; OPIATE; PARACETAMOL; PHOSPHODIESTERASE INHIBITOR; PROPOFOL; REMIFENTANIL; SEVOFLURANE; STEROID; THEOPHYLLINE;

CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DIABETES MELLITUS; ELECTIVE SURGERY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INHALATION ANESTHESIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; INTRAOPERATIVE PERIOD; MAJOR SURGERY; METABOLISM; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK; SIGNAL TRANSDUCTION; STRESS; SURGICAL PATIENT; PEROPERATIVE COMPLICATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; SECRETION;

BLOOD GLUCOSE; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SIGNAL TRANSDUCTION;

EID: 76249105386     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c6be63     Document Type: Review

References (181)

1. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355:1903-1911
2. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009;32(suppl 1):S13-S61
3. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294
4. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009;37:1769-1776
5. Hertzer NR, Bena JF, Karafa MT. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 2007;46:271-279
6. Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 2008;108:506-523
7. Puskas F, Grocott HP, White WD, Mathew JP, Newman MF, Bar-Yosef S. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 2007;84:1467-1473
8. Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;58: 921-924 (Pubitemid 40776893)
9. Bochicchio GV, Salzano L, Joshi M, Bochicchio K, Scalea TM. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am Surg 2005;71:171-174
10. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology 2009;110:408-421
11. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297
12. Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 2006;116:1767-1775
13. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85-96
14. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003;89:3-9
15. Cohen P. The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol 2006;7:867-873
16. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004;126:879-887
17. Powers AC. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's principles of internal medicine. 16th ed. New York: McGraw- Hill, 2005:2152-2180
18. Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest 2007;117:24-32
19. Ganong WL. Review of medical physiology. 20th ed. New York, McGraw-Hill 2001;322-343
20. de Weille J, Schmid-Antomarchi H, Fosset M, Lazdunski M. ATP-sensitive K- channels that are blocked by hypoglycemiainducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci USA 1988;85:1312-1316
21. Carli F, Ronzoni G, Webster J, Khan K, Elia M. The independent metabolic effects of halothane and isoflurane anaesthesia. Acta Anaesthesiol Scand 1993;37:672-678
22. Diltoer M, Camu F. Glucose homeostasis and insulin secretion during isoflurane anesthesia in humans. Anesthesiology 1988;68:880-886
23. Saho S, Kadota Y, Sameshima T, Miyao J, Tsurumaru T, Yoshimura N. The effects of sevoflurane anesthesia on insulin secretion and glucose metabolism in pigs. Anesth Analg 1997;84:1359-1365
24. Iwasaka H, Itoh K, Miyakawa H, Kitano T, Taniguchi K, Honda N. Glucose intolerance during prolonged sevoflurane anaesthesia. Can J Anaesth 1996;43:1059-1061
25. Crozier TA, Morawietz A, Drobnik L, Rieke H, Sydow M, Radke J, Kettler D. The influence of isoflurane on perioperative endocrine and metabolic stress responses. Eur J Anaesthesiol 1992;9:55-62
26. Magnusson J, Nybell-Lindahl G, Tranberg KG. Clearance and action of insulin during general or epidural anaesthesia. Clin Nutr 1986;5:159-165
27. Jensen CH, Berthelsen P, Kuhl C, Kehlet H. Effect of epidural analgesia on glucose tolerance during surgery. Acta Anaesthesiol Scand 1980;24:472-474
28. Oyama T, Takazawa T. Effects of diethyl ether anaesthesia and surgery on carbohydrate and fat metabolism in man. Can Anaesth Soc J 1971;18:51-59
29. Schricker T, Lattermann R, Fiset P, Wykes L, Carli F. Integrated analysis of protein and glucose metabolism during surgery: effects of anesthesia. J Appl Physiol 2001;91:2523-2530
30. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentrationindependent manner. J Anesth 2005;19:277-281
31. Geisser W, Schreiber M, Hofbauer H, Lattermann R, Fussel S, Wachter U, Georgieff M, Schricker T. Sevoflurane versus isoflurane-anaesthesia for lower abdominal surgery. Effects on perioperative glucose metabolism. Acta Anaesthesiol Scand 2003;47:174-179
32. Schricker T, Galeone M, Wykes L, Carli F. Effect of desflurane/ remifentanil anaesthesia on glucose metabolism during surgery: a comparison with desflurane/epidural anaesthesia. Acta Anaesthesiol Scand 2004;48:169-173
33. Schricker T, Carli F, Schreiber M, Wachter U, Geisser W, Lattermann R, Georgieff M. Propofol/sufentanil anesthesia suppresses the metabolic and endocrine response during, not after, lower abdominal surgery. Anesth Analg 2000;90:450-455
34. Li Y, Eitan S, Wu J, Evans CJ, Kieffer B, Sun X, Polakiewicz RD. Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 2003;23:6255-6266
35. Sebel PS, Bovill JG, Schellekens AP, Hawker CD. Hormonal responses to high-dose fentanyl anaesthesia. A study in patients undergoing cardiac surgery. Br J Anaesth 1981;53:941-948
36. Belhoula M, Ciebiera JP, De La Chapelle A, Boisseau N, Coeurveille D, Raucoules-Aime M. Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery. Br J Anaesth 2003;90:434-439
37. Lattermann R, Schricker T, Georgieff M, Schreiber M. Low dose clonidine premedication accentuates the hyperglycemic response to surgery. Can J Anaesth 2001;48:755-759
38. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001;86:650-656
39. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806
40. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002;13: 444-451
41. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-1454
42. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene 2008;27:2320-2336
43. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M, Unterman TG. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 2006;281:10105-10117
44. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904
45. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86:3257-3265
46. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001;89:1191-1198
47. Browne JA, Cook C, Pietrobon R, Bethel MA, Richardson WJ. Diabetes and early postoperative outcomes following lumbar fusion. Spine 2007;32:2214-2219
48. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360
49. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA 2002;288:2167-2169
50. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003;29:642-645
51. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38:1031-1035
52. Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg 2006;243:845-851
53. Schricker T, Lattermann R, Schrieiber M, Geisser W, Georgieff M, Radermacher P. The Hypergycaemic response to surgery: pathophysiology, clinical implications and modification by the anaesthetic technique. Clin Intensive Care 1998;9:118-128
54. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2: 69-78
55. Albacker T, Carvalho G, Schricker T, Lachapelle K. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008;86:20-27
56. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982
57. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005;80:1558-1567
58. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008;36: 2249-2255
59. McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr 2005;25:9-35
60. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-534
61. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000;128:757-760
62. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006;68: 123-158
63. Thorell A, Nygren J, Hirshman MF, Hayashi T, Nair KS, Horton ES, Goodyear LJ, Ljungqvist O. Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization. Am J Physiol 1999;276:E754-61
64. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006;368:1-19
65. Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Insulin resistance after abdominal surgery. Br J Surg 1994;81:59-63
66. Clarke RS. The hyperglycaemic response to different types of surgery and anaesthesia. Br J Anaesth 1970;42:45-53
67. Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 1993;159:593-599
68. Thorell A, Nygren J, Essen P, Gutniak M, Loftenius A, Andersson B, Ljungqvist O. The metabolic response to cholecystectomy: insulin resistance after open compared with laparoscopic operation. Eur J Surg 1996;162:187-191
69. Schricker T, Berroth A, Pfeiffer U, Schreiber M, Malik E, Schmidt M, Goertz A, Georgieff M. Influence of vaginal versus abdominal hysterectomy on perioperative glucose metabolism. Anesth Analg 1996;83:991-995
70. Kuntschen FR, Galletti PM, Hahn C. Glucose-insulin interactions during cardiopulmonary bypass. Hypothermia versus normothermia. J Thorac Cardiovasc Surg 1986;91:451-459
71. Rassias AJ. Intraoperative management of hyperglycemia in the cardiac surgical patient. Semin Thorac Cardiovasc Surg 2006;18:330-338
72. Lukins MB, Manninen PH. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg 2005;100: 1129-1133
73. Lehot JJ, Piriz H, Villard J, Cohen R, Guidollet J. Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. Chest 1992;102:106-111
74. Braden H, Cheema-Dhadli S, Mazer CD, McKnight DJ, Singer W, Halperin ML. Hyperglycemia during normothermic cardiopulmonary bypass: the role of the kidney. Ann Thorac Surg 1998;65:1588-1593
75. Lattermann R, Belohlavek G, Wittmann S, Fuchtmeier B, Gruber M. The anticatabolic effect of neuraxial blockade after hip surgery. Anesth Analg 2005;101:1202-1208
76. Naito Y, Tamai S, Shingu K, Shindo K, Matsui T, Segawa H, Nakai Y, Mori K. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992;77:426-431
77. Traynor C, Hall GM. Endocrine and metabolic changes during surgery: anaesthetic implications. Br J Anaesth 1981;53:153-160
78. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005;80:862-866
79. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144-1151
80. Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Dunkelgrun M, Bax JJ, Klein J, Poldermans D. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007;156:137-142 (Pubitemid 46553914)
81. Aristedis R, Serafim K. The influence of hyperglycemia on neurological outcomes in patients with severe head injury. Neurosurgery 2000;46:335-342
82. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003;55:33-38
83. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004;56:1058-1062
84. Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;59:80-83 (Pubitemid 41271642)
85. McGirt MJ, Woodworth GF, Brooke BS, Coon AL, Jain S, Buck D, Huang J, Clatterbuck RE, Tamargo RJ, Perler BA. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006;58:1066-1073
86. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006;141:375-380
87. Hill SE, van Wermeskerken GK, Lardenoye JW, Phillips-Bute B, Smith PK, Reves JG, Newman MF. Intraoperative physiologic variables and outcome in cardiac surgery: Part I. Inhospital mortality. Ann Thorac Surg 2000;69:1070-1075
88. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002;49:531-537
89. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003;75:1392-1399
90. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021
91. D'Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A, Gandjbakhch I, Bonnet N. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007;134:29-37
92. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047
93. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 2003;26:1518-1524
94. Vriesendorp TM, Morelis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004;28:520-525
95. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478
96. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 2007;73:454-460
97. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea- Mahler E, Johnson D, Henske J, McCarthy PM, Gleason TG, McGee EC, Molitch ME. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007;30:823-828
98. Reed CC, Stewart RM, Sherman M, Myers JG, Corneille MG, Larson N, Gerhardt S, Beadle R, Gamboa C, Dent D, Cohn SM, Pruitt BA Jr. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007;204:1048-1054
99. Wahl WL, Taddonio M, Maggio PM, Arbabi S, Hemmila MR. Mean glucose values predict trauma patient mortality. J Trauma 2008;65:42-47
100. Ascione R, Rogers CA, Rajakaruna C, Angelini GD. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 2008;118:113-123
101. Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008;12:R29
102. Meier R, Bechir M, Ludwig S, Sommerfeld J, Keel M, Steiger P, Stocker R, Stover JF. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care 2008;12:R98
103. Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, Rogers SO. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008;248:585-591
104. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS, Kassell NF, Nemergut EC. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 2009;110:603-610
105. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, Fraser VJ. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008;90:62-69
106. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005;103:687-694
107. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146: 233-243
108. Pasternak JJ, McGregor DG, Schroeder DR, Lanier WL, Shi Q, Hindman BJ, Clarke WR, Torner JC, Weeks JB, Todd MM. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 2008;83:406-417
109. Vriesendorp TM, DeVries JH, Hulscher JB, Holleman F, van Lanschot JJ, Hoekstra JB. Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial. Crit Care 2004; 8:R437-42
110. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002;94:1113-1119
111. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002;123:928-935
112. Butterworth J, Wagenknecht LE, Legault C, Zaccaro DJ, Kon ND, Hammon JW Jr, Rogers AT, Troost BT, Stump DA, Furberg CD, Coker LH. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2005;130:1319
113. Koskenkari JK, Kaukoranta PK, Kiviluoma KT, Raatikainen MJ, Ohtonen PP, AL-Kokko TI. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 2005;80:511-517
114. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367
115. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(suppl 2):46-52
116. Hoedemaekers CW, Pickkers P, Netea MG, van Deuren M, Van der Hoeven JG. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. Crit Care 2005;9:R790 -97
117. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156-160
118. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, Santoro A, Rosa G. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008;9:159-166
119. Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009;110:611-619
120. Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD, Sundar E, Bose R, Pomposelli F, Kersten JR, Talmor DS. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology 2009;110:970-977
121. Houle TT. Reporting the results of a study that did not go according to plan. Anesthesiology 2009;110:957-958
122. Bilotta F, Giovannini F, Caramia R, Rosa G. Glycemia management in neurocritical care patients: a review. J Neurosurg Anesthesiol 2009;21:2-9
123. Kloner RA, Nesto RW. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation 2008;117:2523-2533
124. Donatelli F, Cavagna P, Di Dedda G, Catenacci A, Di Nicola M, Lorini L, Fumagalli R, Carli F. Correlation between preoperative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients. Acta Anaesthesiol Scand 2008;52:1103-1110
125. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc 2009;84:400-402
126. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004;164:2005-2011
127. Gandhi GY, Murad MH, Flynn DN, Erwin PJ, Cavalcante AB, Bay Nielsen H, Capes SE, Thorlund K, Montori VM, Devereaux PJ. Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials. Mayo Clin Proc 2008;83:418-430
128. Brunkhorst FM, Englel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
129. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-3197
130. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461
131. Glucontrol Study: Comparing the Effects of Two Glucose control Regimens by Insulin in Intensive Care Unit Patients. Available at: http://clinicaltrials. gov/ct2/show/NCT00107601. Accessed May 21, 2009
132. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-944
133. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-827
134. Watkinson P, Barber VS, Young JD. Strict glucose control in the critically ill. BMJ 2006;332:865-866
135. McCormick MT, Muir KW, Gray CS, Walters MR. Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke 2008;39:2177-2185
136. Lacherade JC, Jabre P, Bastuji-Garin S, Grimaldi D, Fangio P, Theron V, Outin H, De Jonghe B. Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med 2007;33:814-821
137. Nasraway SA Jr. Sitting on the horns of a dilemma: avoiding severe hypoglycemia while practicing tight glycemic control. Crit Care Med 2007;35:2435-2437
138. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35:2262-2267
139. Inzucchi SE, Siegel MD. Glucose control in the ICU-how tight is too tight? N Engl J Med 2009;360:1346-1349
140. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008;117:1018-1027
141. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-ofcare testing for glucose measurement in critically ill adults. Crit Care Med 2005;33:2778-2785
142. For Falsely Elevated Glucose Readings From Use of Inappropriate Test method. Available at: http://www.fda.gov/cdrh/oivd/ news/glucosefalse.html. FDA Reminders. Accessed May 29, 2009
143. MEDMARX- Data Report. A Report on the Relationship of Drug Names and Medication Errors in Response to the Institute of Medicine's Call for Action. U.S. Pharmacopeia, 2008
144. Runy LA. A guide to the safer use of dangerous medications. High-Alert medications. Hosp Health Netw 2004;78:67-73
145. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252
146. Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF Jr, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008;36:2316-2321
147. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181
148. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-3013
149. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007;30: 1005-1011
150. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P, Li W, Bates S. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med 2006;173:407-413
151. Fowler RA, Annane D. The highs and lows of intensive insulin therapy. Am J Respir Crit Care Med 2006;173:367-369
152. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009;119:351-357
153. van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-3159
154. Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005;33:2772-2777
155. Krinsley JS. Blood glucose control in critically ill patients: the impact of diabetes. Crit Care Med 2009;37:382
156. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;8:436-472 (Pubitemid 34174577)
157. Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem 2009;55:18-20
158. Brunkhorst FM, Wahl HG. Blood glucose measurements in the critically ill: more than just a blood draw. Crit Care 2006;10:178
159. D'Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Kulpmann WR, Larsson L, Lewenstam A, Maas AH, Mager G, Naskalski JW, Okorodudu AO. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med 2006;44:1486-1490
160. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007;30:403-409
161. Kulkarni A, Saxena M, Price G, O'Leary MJ, Jacques T, Myburgh JA. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med 2005;31:142-145
162. Atkin SH, Dasmahapatra A, Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med 1991;114:1020-1024
163. Sylvain HF, Pokorny ME, English SM, Benson NH, Whitley TW, Ferenczy CJ, Harrison JG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care 1995;4:44-48
164. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008;83:400-405
165. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, Willems JL, Van der Hoeven JG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 2008;36:3062-3066
166. Fahy BG, Coursin DB. Critical glucose control: the devil is in the details. Mayo Clin Proc 2008;83:394-397
167. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006;15:370-377
168. Intensive Insulin Therapy. Anesthesia Patient Safety Foundation Newsletter 2007;22:37
169. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Englelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268
170. Sheehy AM, Coursin DB, Gabbay RA. Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus. Mayo Clin Proc 2009;84:38-42
171. Moghissi ES, Korytkowski MT, Dinardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care 2009;32:1119-1131
172. Association CD. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2008;32:S72-S73
173. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007;116:e418-99
174. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Englelman RM, Sadhu AR, Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009;87:663-669
175. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008;31(suppl 1):S12-S54
176. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(suppl 1):1-68
177. Surgical Care Improvement Project. Available at: http:// www.cfmc.org/hospital/hospital-scip.html. Accessed May 21, 2009
178. Effects of Steroids, Controlling Blood Sugar Levels, and Avoidance of Deep Anesthesia on patient Outcomes After Major Vascular Surgery (DeLiT). Available at: http://clinicaltrials. gov/ct2/show/NCT00433251. Accessed May 21, 2009
179. Tight Intra-Operative Glucose control During Coronary Artery Bypass Surgery. Available at: http://clinicaltrials.gov/ct2/ show/NCT00394303. Accessed May 21, 2009
180. Outcomes Study of Hyperinsulinemic Glucose control in Cardiac Surgery. Available at: http://clinicaltrials.gov/ct2/show/ NCT00524472. Accessed May 21, 2009
181. Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery. Available at: http://clinicaltrials.gov/ct2/show/ NCT00836329. Accessed May 21, 2009